SEC Form 4 · accession 0001209191-15-002426
Axogen, Inc. · AXGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John Frederick Harper
Director
Period of report
Jan 2, 2014
Accepted (ET)
Jan 6, 2015 · 5:44 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000805928
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to purchase)F1 | $4.81 | Jan 2, 2014 | A | 15,000 | A | Mar 31, 2014 | Jan 1, 2021 | Common Stock | 15,000 | 57,542 | D |
| Stock Option (right to purchase)F1 | $3.60 | Jan 2, 2015 | A | 15,000 | A | Mar 31, 2015 | Jan 1, 2022 | Common Stock | 15,000 | 72,542 | D |
Explanation of responses
- F1Annual option grant as compensation for services on the board of directors. Options vest as to 25% of total share amount at the end of each fiscal quarter, becoming fully vested after one year.